Supriya Life Sciences Share Price

ABOUT Supriya Life Sciences

• Industry Biotechnology & Drugs
• ISIN INE07RO01027
• BSE Code 543434
• NSE Code SUPRIYA

Supriya Lifescience Limited is an India-based manufacturer of active pharmaceutical ingredients (APIs). The Company is primarily engaged in manufacturing of bulk drugs and pharmaceutical chemicals. The Company exports its products in the antihistamine, anesthetics and anti-asthma therapy categories to approximately 86 countries. The Company's product portfolio consists of approximately 38 niche API products that address remedies in therapeutic segments, such as antihistamine, analgesic, vitamin, anesthetics and anti-asthmatics, among others. Its products include Chlorphenamine Maleate, Pheniramine Maleate, Brompheniramine Maleate, Dexchlorpheniramine Maleate, Mepyramine / Pyrilamine Maleate, Dexbrompheniramine Maleate, Cetirizine DiHCL, Diphenhydramine HCL, Bisoprolol Fumarate, Nicorandil, Mecobalamin, Hydroxocobalamin Sulphate, Hydroxocobalamin Acetate, and Hydroxocobalamin Hydrochloride, among others. The Company has manufacturing facilities located in Maharashtra.

MANAGEMENT

• Satish Wagh Executive Chairman of the Board
• Krishna Raghunathan Chief Financial Officer
• Shweta Singh Chief Compliance Officer, Company Secretary
• Saloni Wagh Managing Director, Whole-Time Director
• Shivani Wagh Joint Managing Director, Whole-Time Director
• Balasaheb Sawant Whole-Time Director
• Smita Wagh Whole-Time Director